Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis

被引:93
作者
Chang, Yu-Ting [1 ]
Chang, Ming-Chu [1 ]
Su, Ta-Chen [1 ,2 ]
Liang, Po-Chin [3 ]
Su, Yi-Ning [4 ]
Kuo, Chun-Hung [1 ]
Wei, Shu-Chen [1 ]
Wong, Jau-Min [1 ]
机构
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei 10764, Taiwan
[2] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan
[3] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Radiol, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Med Genet, Taipei 10764, Taiwan
关键词
D O I
10.1373/clinchem.2007.093492
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: The mechanism by which hypertriglyceridemia (HTG) leads to pancreatitis is not clear. We sought to determine whether the genes involved in pancreatic ductal or acinar cell injury, including the cationic trypsinogen gene [protease, serine, 1 (trypsin 1) (PRSS1)], the pancreatic secretory trypsin inhibitor gene [serine peptidase inhibitor, Kazal type I (SPINK1)], the cystic fibrosis transmembrane conductance regulator gene [cystic fibrosis transmembrane conductance regulator (ATP-binding cassette subfamily C, member 7) (CFTR)], and inflammation genes such as tumor necrosis factor [tumor necrosis factor, TNF superfamily, member 2 (TNF)] are associated with hyperlipidemic pancreatitis (HLP) in patients with HTG. METHODS: We performed genetic analysis of 126 HTG patients in Taiwan (46 with HLP and 80 without HLP). The entire coding and intronic regions of the PRSS1, SPINK1, and CFTR genes were identified by heteroduplex analysis techniques and were confirmed by sequencing analysis. The presence of 125G/C, 1001 + IIC>T, 1540A>G (Met470Val), 2694T>G, and 4521G>A in CFTR, the presence of 272C>T in SPINK1, and TNF promoter polymorphisms (nucleotide positions 1031, 863, 857, 308, and 308) were measured by direct sequencing. RESULTs: Of the 126 HTG patients, 13 (10.3%) carried a CFTR mutation. No PRSS1 or SPINK1 mutations were detected in our patients or in HTG controls. The CFTR gene mutation rates in HTG with and without HLP were 26.1% (12 of 46) and 1.3% (1 of 80), respectively (P <0.0001). The CFTR gene mutations were all Ile556Val. A multivariate analysis of HTG patients indicated that triglycerides, CFTR 470Val, and TNF promoter 863A were independent risk markers for HLP. CONCLUSIONS: This genetic study is the first one to address the association of HLP with the CFTR mutation/ variant/haplotype and TNF promoter polymorphism in a Chinese HTG population. The results suggest that the occurrence of HLP is multifactorial and polygenic. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 33 条
[11]   Genetic analysis of case/control data using estimated haplotype frequencies: Application to APOE locus variation and Alzheimer's disease [J].
Fallin, D ;
Cohen, A ;
Essioux, L ;
Chumakov, I ;
Blumenfeld, M ;
Cohen, D ;
Schork, NJ .
GENOME RESEARCH, 2001, 11 (01) :143-151
[12]   HYPERLIPOPROTEINEMIA AND PANCREATITIS [J].
FARMER, RG ;
WINKELMAN, EI ;
BROWN, HB ;
LEWIS, LA .
AMERICAN JOURNAL OF MEDICINE, 1973, 54 (02) :161-165
[13]  
FORTSON MR, 1995, AM J GASTROENTEROL, V90, P2134
[14]   IDENTIFICATION OF 8 MUTATIONS AND 3 SEQUENCE VARIATIONS IN THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE [J].
GHANEM, N ;
COSTES, B ;
GIRODON, E ;
MARTIN, J ;
FANEN, P ;
GOOSSENS, M .
GENOMICS, 1994, 21 (02) :434-436
[15]  
Havel R J, 1969, Adv Intern Med, V15, P117
[16]   Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan [J].
Jap, TS ;
Jenq, SF ;
Wu, YC ;
Chiu, CY ;
Cheng, HM .
PANCREAS, 2003, 27 (02) :122-126
[17]   A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases [J].
Lee, JH ;
Choi, JH ;
Namkung, W ;
Hanrahan, JW ;
Chang, J ;
Song, SY ;
Park, SW ;
Kim, DS ;
Yoon, JH ;
Suh, Y ;
Jang, IJ ;
Nam, JH ;
Kim, SJ ;
Cho, MO ;
Lee, JE ;
Kim, KH ;
Lee, MG .
HUMAN MOLECULAR GENETICS, 2003, 12 (18) :2321-2332
[18]   Identification of Forty-Five Novel and Twenty-Three Known NF1 Mutations in Chinese Patients With Neurofibromatosis Type 1 [J].
Lee, Ming-Jen ;
Su, Yi-Ning ;
You, Huey-Ling ;
Chiou, Shinn-Chong ;
Lin, Li-Chu ;
Yang, Chih-Chao ;
Lee, Wang-Chao ;
Hwu, Wu-Liang ;
Hsieh, Fon-Jou ;
Stephenson, Dennis A. ;
Yu, Chia-Li .
HUMAN MUTATION, 2006, 27 (08) :832
[19]   Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Asians with chronic pulmonary disease: A pilot study [J].
Ngiam, Nicola S. P. ;
Chong, Samuel S. ;
Shek, Lynette P. C. ;
Goh, Denise L. M. ;
Ong, K. C. ;
Chng, S. Y. ;
Yeo, G. H. ;
Goh, Daniel Y. T. .
JOURNAL OF CYSTIC FIBROSIS, 2006, 5 (03) :159-164
[20]   Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection [J].
O'Donovan, MC ;
Oefner, PJ ;
Roberts, SC ;
Austin, J ;
Hoogendoorn, B ;
Guy, C ;
Speight, G ;
Upadhyaya, M ;
Sommer, SS ;
McGuffin, P .
GENOMICS, 1998, 52 (01) :44-49